Related Experiment Videos
Interleukin-1 and neuronal injury
Stuart M Allan1, Pippa J Tyrrell, Nancy J Rothwell
1Faculty of Life Sciences, The University of Manchester, Michael Smith Building, Manchester M13 9PT, UK. stuart.allan@manchester.ac.uk
Nature Reviews. Immunology
|July 22, 2005
Summary
Interleukin-1 (IL-1) drives neuronal injury in acute neurodegenerative conditions like stroke. Targeting the IL-1 system offers a promising therapeutic strategy for these conditions.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Interleukin-1 (IL-1) is a pro-inflammatory cytokine with diverse biological functions.
- IL-1 plays a role in inflammatory processes, acute-phase protein induction, and neuroimmune responses.
- Evidence suggests IL-1 directly contributes to neuronal injury in neurodegenerative disorders.
Purpose of the Study:
- To review the evidence implicating IL-1 in acute neurodegeneration.
- To explore the rationale for targeting the IL-1 system therapeutically.
Main Methods:
- Review of existing scientific literature and evidence.
- Discussion of IL-1's role in specific conditions like stroke and brain trauma.
Main Results:
- Extensive evidence supports IL-1's involvement in acute neuronal injury.
- IL-1 directly impacts brain function and neuroinflammation.
Conclusions:
- Interleukin-1 is a key mediator of neuronal damage in acute neurodegenerative events.
- Targeting the IL-1 system presents a viable therapeutic avenue for conditions such as stroke and traumatic brain injury.